Jessica Sprague, MD
Pediatric Dermatology · San Diego, CANPI 1437594884
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Pfizer at 30.3% of the total. That places this record below the midpoint for pediatric dermatology clinicians in CA, where the typical reported total is $1,656.
Across 35 payments — averaging $26.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$277
- Sanofi$164
- Sanofi-aventis U.S. LLC$99
- Regeneron Healthcare Solutions, Inc.$93
- AbbVie$87
- Amgen$52
- plus $143 from 7 others
What the payments were for
- Food & beverage$916100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 13 | $277 |
| Sanofi | 4 | $164 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Regeneron Healthcare Solutions, Inc. | 1 | $93 |
| AbbVie | 4 | $87 |
| Amgen | 2 | $52 |
| Pierre Fabre Pharmaceuticals, Inc. | 2 | $26 |
| Lilly USA, LLC | 1 | $26 |
| Johnson & Johnson | 1 | $24 |
| Organon | 3 | $19 |
| GSK | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Lumenis, Inc | 1 | $11 |
How this compares
$916 in reported general payments places this provider in the 40th percentile of 36 pediatric dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 19 | $3,898 |
| Calcipotriene | 11 | $2,905 |
| Fluorouracil | 21 | $1,561 |
| Ketoconazole | 73 | $1,142 |
| Clindamycin Phosphate | 28 | $741 |
| Betamethasone Dipropionate | 20 | $674 |
| Fluocinonide | 19 | $557 |
| Triamcinolone Acetonide | 56 | $556 |
| Clobetasol Propionate | 17 | $531 |
| Hydrocortisone | 37 | $316 |
| Mupirocin | 14 | $134 |
Paid to pharmacies, not to this prescriber.
Other pediatric dermatology in San Diego
- Lawrence EichenfieldSan Diego$2.8M
- Dawn EichenfieldSan Diego$252K
- Sheila FriedlanderSan Diego$7K
- Wynnis TomSan Diego$4K
- Bari CunninghamSan Diego$3K
- Allison HanSan Diego$1K
- Catalina MatizSan Diego$672
- David SchairerSan Diego$630
- Susan BoikoSan Diego$527
- Magdalene DohilSan Diego$444
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.